# MoonLake Immunotherapeutics: filings

MLTX · Nasdaq · CIK 1821586 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mltx.md) · [Financials](/companies/mltx/financials.md) · [Filings](/companies/mltx/filings.md) · [Insiders](/companies/mltx/insiders.md)

## Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 81, 8-K 53, 10-Q 18, 3 16, SC 13G/A 15, CORRESP 14, UPLOAD 14, 144 13, DEFA14A 10, SC 13G 10, SCHEDULE 13G/A 9, S-1/A 7, 10-K 6, 424B5 6, EFFECT 6, 424B3 5, SCHEDULE 13G 5, ARS 4, DEF 14A 4, PRER14A 4, SC 13D/A 3, SCHEDULE 13D/A 3, 10-K/A 2, POS AM 2, S-1 2, S-3 2, S-8 2, 10-Q/A 1, 424B4 1, 425 1, 8-A12B 1, 8-K/A 1, CERT 1, DEFM14A 1, DEFR14A 1, DRS 1, NT 10-Q 1, PREM14A 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 16:15 ET | [8-K](/filings/0001213900-26-105240.md) | 8.01 Other events | 0001213900-26-105240 |
| 2026-08-10 | 07:46 ET | [10-Q](/filings/0001821586-26-000010.md) | Quarterly report, period 2026-06-30 | 0001821586-26-000010 |
| 2026-08-10 | 07:15 ET | [8-K](/filings/0001213900-26-086939.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-086939 |
| 2026-07-15 | 17:31 ET | [8-K](/filings/0001213900-26-078031.md) | 8.01 Other events | 0001213900-26-078031 |
| 2026-06-29 | 17:20 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001697.md) | Ownership report, active investor, amended | 0000921895-26-001697 |
| 2026-06-25 | 06:18 ET | [8-K](/filings/0001213900-26-071721.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-071721 |
| 2026-06-22 | 07:00 ET | [8-K](/filings/0001213900-26-070362.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-070362 |
| 2026-06-09 | 16:30 ET | [8-K](/filings/0001213900-26-066821.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-066821 |
| 2026-06-01 | 06:20 ET | [8-K](/filings/0001213900-26-063125.md) | 1.01 Entry into a material agreement | 0001213900-26-063125 |
| 2026-05-11 | 08:55 ET | [10-Q](/filings/0001821586-26-000007.md) | Quarterly report, period 2026-03-31 | 0001821586-26-000007 |
| 2026-05-11 | 07:09 ET | [8-K](/filings/0001821586-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001821586-26-000005 |
| 2026-04-21 | 16:30 ET | [DEF 14A](/filings/0001140361-26-015916.md) | Proxy statement, period 2026-06-04 | 0001140361-26-015916 |
| 2026-04-02 | 16:44 ET | [SCHEDULE 13D/A](/filings/0000921895-26-000894.md) | Ownership report, active investor, amended | 0000921895-26-000894 |
| 2026-02-25 | 06:12 ET | [10-K](/filings/0001821586-26-000002.md) | Annual report, period 2025-12-31 | 0001821586-26-000002 |
| 2026-02-23 | 06:04 ET | [8-K](/filings/0001213900-26-018967.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-018967 |
| 2026-01-08 | 08:00 ET | [8-K](/filings/0001213900-26-002344.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002344 |
| 2025-11-10 | 17:27 ET | [SCHEDULE 13D/A](/filings/0000921895-25-002943.md) | Ownership report, active investor, amended | 0000921895-25-002943 |
| 2025-11-05 | 17:26 ET | [8-K](/filings/0001213900-25-106723.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-106723 |
| 2025-11-05 | 07:02 ET | [10-Q](/filings/0001821586-25-000022.md) | Quarterly report, period 2025-09-30 | 0001821586-25-000022 |
| 2025-11-05 | 07:00 ET | [8-K](/filings/0001821586-25-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001821586-25-000021 |
| 2025-09-29 | 07:15 ET | [8-K](/filings/0001213900-25-092614.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-092614 |
| 2025-08-05 | 07:04 ET | [10-Q](/filings/0001821586-25-000018.md) | Quarterly report, period 2025-06-30 | 0001821586-25-000018 |
| 2025-08-05 | 07:01 ET | [8-K](/filings/0001821586-25-000016.md) | 2.02 Results of operations | 0001821586-25-000016 |
| 2025-06-06 | 16:30 ET | [8-K](/filings/0001213900-25-052140.md) | 5.07 Shareholder vote results | 0001213900-25-052140 |
| 2025-05-12 | 16:04 ET | [10-Q](/filings/0001821586-25-000011.md) | Quarterly report, period 2025-03-31 | 0001821586-25-000011 |
| 2025-05-12 | 16:01 ET | [8-K](/filings/0001821586-25-000009.md) | 2.02 Results of operations | 0001821586-25-000009 |
| 2025-04-29 | 07:05 ET | [8-K](/filings/0001213900-25-036363.md) | 7.01 Regulation FD disclosure | 0001213900-25-036363 |
| 2025-04-22 | 16:30 ET | [DEF 14A](/filings/0001140361-25-014923.md) | Proxy statement, period 2025-06-05 | 0001140361-25-014923 |
| 2025-04-03 | 07:05 ET | [8-K](/filings/0001213900-25-028366.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-028366 |
| 2025-02-26 | 07:13 ET | [10-K](/filings/0001821586-25-000006.md) | Annual report, period 2024-12-31 | 0001821586-25-000006 |
| 2025-02-26 | 07:09 ET | [8-K](/filings/0001821586-25-000004.md) | 2.02 Results of operations | 0001821586-25-000004 |
| 2024-12-18 | 16:30 ET | [8-K](/filings/0001213900-24-110169.md) | 5.02 Departure or appointment of officers or directors | 0001213900-24-110169 |
| 2024-11-07 | 07:05 ET | [10-Q](/filings/0001821586-24-000029.md) | Quarterly report, period 2024-09-30 | 0001821586-24-000029 |
| 2024-11-07 | 07:03 ET | [8-K](/filings/0001821586-24-000028.md) | 2.02 Results of operations | 0001821586-24-000028 |
| 2024-10-08 | 18:48 ET | [SC 13D/A](/filings/0000921895-24-002262.md) | Ownership report, active investor, amended | 0000921895-24-002262 |
| 2024-09-11 | 07:30 ET | [8-K](/filings/0001213900-24-077513.md) | 7.01 Regulation FD disclosure | 0001213900-24-077513 |
| 2024-08-07 | 08:04 ET | [10-Q](/filings/0001821586-24-000025.md) | Quarterly report, period 2024-06-30 | 0001821586-24-000025 |
| 2024-08-07 | 08:02 ET | [8-K](/filings/0001821586-24-000024.md) | 2.02 Results of operations | 0001821586-24-000024 |
| 2024-06-10 | 16:40 ET | [8-K](/filings/0001213900-24-051263.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-051263 |
| 2024-06-06 | 07:30 ET | [8-K](/filings/0001213900-24-050194.md) | 5.07 Shareholder vote results | 0001213900-24-050194 |
| 2024-05-07 | 08:02 ET | [10-Q](/filings/0001821586-24-000020.md) | Quarterly report, period 2024-03-31 | 0001821586-24-000020 |
| 2024-05-07 | 08:01 ET | [8-K](/filings/0001821586-24-000019.md) | 2.02 Results of operations | 0001821586-24-000019 |
| 2024-05-07 | 07:57 ET | [10-K/A](/filings/0001821586-24-000018.md) | Annual report, amended, period 2023-12-31 | 0001821586-24-000018 |
| 2024-04-24 | 16:30 ET | [DEF 14A](/filings/0001140361-24-021744.md) | Proxy statement, period 2024-06-05 | 0001140361-24-021744 |
| 2024-03-11 | 08:01 ET | [8-K](/filings/0001213900-24-021233.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-021233 |
| 2024-03-05 | 16:59 ET | [SC 13D/A](/filings/0000921895-24-000582.md) | Ownership report, active investor, amended | 0000921895-24-000582 |
| 2024-02-29 | 08:05 ET | [10-K](/filings/0001821586-24-000008.md) | Annual report, period 2023-12-31 | 0001821586-24-000008 |
| 2024-02-29 | 08:03 ET | [8-K](/filings/0001821586-24-000007.md) | 2.02 Results of operations | 0001821586-24-000007 |
| 2024-02-26 | 09:00 ET | [8-K](/filings/0001213900-24-016737.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-016737 |
| 2023-11-14 | 08:05 ET | [10-Q](/filings/0001821586-23-000022.md) | Quarterly report, period 2023-09-30 | 0001821586-23-000022 |

Page 1 of 3. [Older](/companies/mltx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.